Your browser doesn't support javascript.
loading
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.
Oliveira, Mariana M S; D'Aulerio, Roberta; Yong, Tracer; He, Minghui; Baptista, Marisa A P; Nylén, Susanne; Westerberg, Lisa S.
Afiliação
  • Oliveira MMS; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • D'Aulerio R; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • Yong T; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • He M; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • Baptista MAP; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
  • Nylén S; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • Westerberg LS; Department of Microbiology Tumor and Cell biology, Karolinska Institutet, 17177, Stockholm, Sweden. lisa.westerberg@ki.se.
Br J Cancer ; 128(6): 982-991, 2023 04.
Article em En | MEDLINE | ID: mdl-36631633
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Apresentação Cruzada Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Apresentação Cruzada Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article